Bachem Holding AG (BANB.SW) SIX
69.05
-1.95(-2.75%)
Currency In CHF
- General
- Statistics
- Historical Data
- Profile
- Financials
69.05
-1.95(-2.75%)
Currency In CHF
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2207
First IPO Date
July 17, 1998
| Name | Title | Pay | Year Born |
| Anne-Kathrin Stoller | Chief Executive Officer | 0 | 1974 |
| Hans van Hees | Chief Operations Officer | 0 | 1969 |
| Achim Pluckebaum | Chief Information Officer | 0 | N/A |
| Gunther Loidl | Chief Technology Officer | 0 | 1970 |
| Daniel Grotzky | Head of Group Communications | 0 | N/A |
| Barbora Blaha | Head of Investor Relations | 0 | N/A |
| Alain Schaffter | Chief Financial Officer | 0 | 1977 |
| Torsten Wohr | Chief Commercial Officer | 0 | 1968 |
| Michael Suter | Vice President of Global Accounting | 0 | N/A |
| Viviane Minden | Chief Human Resources Officer | 0 | N/A |
Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.